| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 8 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| 2 | TACROLIMUS OINTMENT 0.1% | 8 |
| 3 | METHYLPREDNISOLONE | 7 |
| 4 | MYCOPHENOLATE MOFETIL | 6 |
| 5 | BORTEZOMIB | 4 |
| 6 | PREDNISONE | 4 |
| 7 | CYTARABINE | 3 |
| 8 | RITUXIMAB | 3 |
| 9 | SIROLIMUS | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BRINCIDOFOVIR | 1 | 0.0072 |
| 1 | ARGATROBAN | 1 | 0.0007 |
| 2 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| 3 | RASBURICASE | 1 | 0.0004 |
| 4 | MICAFUNGIN SODIUM | 2 | 0.0003 |
| 5 | SIROLIMUS | 3 | 0.0002 |
| 6 | PYRAZINAMIDE | 2 | 0.0002 |
| 7 | OFLOXACIN OTIC SOLUTION | 1 | 0.0001 |
| 8 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 1 | 0.0001 |
| 9 | OFLOXACIN OTIC | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 1 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 2 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 4 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 5 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 7 | Antimalarial [EPC] | 1 | 0.0001 |
| 8 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 9 | Bile Acid [EPC] | 2 | 0.0001 |